Ophthotech (OPHT) Stake Maintained by Acadian Asset Management Llc; Jlb & Associates Lifted Henry Schein (HSIC) Position by $578,210

August 12, 2018 - By Mary Kidd

Henry Schein, Inc. (NASDAQ:HSIC) Logo

Jlb & Associates Inc increased its stake in Henry Schein (HSIC) by 18.73% based on its latest 2018Q1 regulatory filing with the SEC. Jlb & Associates Inc bought 8,630 shares as the company’s stock rose 4.05% while stock markets declined. The institutional investor held 54,714 shares of the health care company at the end of 2018Q1, valued at $3.68 million, up from 46,084 at the end of the previous reported quarter. Jlb & Associates Inc who had been investing in Henry Schein for a number of months, seems to be bullish on the $11.85 billion market cap company. The stock decreased 1.48% or $1.16 during the last trading session, reaching $77.37. About 908,790 shares traded. Henry Schein, Inc. (NASDAQ:HSIC) has declined 23.14% since August 12, 2017 and is downtrending. It has underperformed by 35.71% the S&P500. Some Historical HSIC News: 03/04/2018 – Hagens Berman Alerts Investors in Henry Schein, Inc., to the May 7, 2018 Lead Plaintiff Deadline in the Securities Class Action; 19/03/2018 – Henry Schein Director Lawrence Bacow Won’t Stand for Re-election at Annual Meeting; 08/05/2018 – Henry Schein Profit Falls on Higher Costs; 23/04/2018 – Henry Schein Sees 3-Yr Operating Income Synergies for Combined Animal Health Businesses in Excess of $100M; 30/04/2018 – Fidelity Growth Strategies Adds NVR, Exits Henry Schein; 28/03/2018 – The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Henry Schein, Inc. Shareholders and a Lead Plaintiff Deadline of May 7, 2018; 03/04/2018 – HENRY SCHEIN INC – REMAINDER OF HENRY SCHEIN ONE’S MANAGEMENT TEAM WILL BE ANNOUNCED AT A LATER DATE; 23/04/2018 – HENRY SCHEIN TO SPIN OFF, MERGE ANIMAL HEALTH BUSINESS W/ VETS; 21/05/2018 – HENRY SCHEIN INC – PROCEEDS OF LOAN WILL BE USED, AMONG OTHER THINGS, TO FUND CO’S PURCHASE OF ALL OF EQUITY INTERESTS IN BUTLER ANIMAL HEALTH HOLDING; 23/04/2018 – Henry Schein to Nominate 6 to Bd, Vets First Choice to Nominate

Acadian Asset Management Llc increased its stake in Ophthotech Corp (OPHT) by 257.13% based on its latest 2018Q1 regulatory filing with the SEC. Acadian Asset Management Llc bought 512,733 shares as the company’s stock rose 6.13% while stock markets declined. The institutional investor held 712,141 shares of the major pharmaceuticals company at the end of 2018Q1, valued at $1.95 million, up from 199,408 at the end of the previous reported quarter. Acadian Asset Management Llc who had been investing in Ophthotech Corp for a number of months, seems to be bullish on the $88.32M market cap company. The stock decreased 2.01% or $0.05 during the last trading session, reaching $2.44. About 42,395 shares traded. Ophthotech Corporation (NASDAQ:OPHT) has risen 18.38% since August 12, 2017 and is uptrending. It has outperformed by 5.81% the S&P500. Some Historical OPHT News: 10/05/2018 – Municipal Employees Retire Sys Of Michigan Buys Into Ophthotech; 09/05/2018 – Ophthotech 1Q Loss $13.1M; 09/05/2018 – OPHTHOTECH 1Q LOSS/SHR 36C, EST. LOSS/SHR 40C (2 EST.); 09/05/2018 – Ophthotech 1Q Loss/Shr 36c; 01/05/2018 – Ophthotech Completes Patient Recruitment in the Phase 2a Clinical Trial of Zimura(R) in Combination With Anti-VEGF Therapy in Wet Age-Related Macular Degeneration; 19/04/2018 DJ Ophthotech Corp, Inst Holders, 1Q 2018 (OPHT); 09/05/2018 – OPHTHOTECH 1Q COLLABORATION REV $0; 01/05/2018 – Ophthotech Initial Top-line Data for Study Expected by the End of 2018

Among 13 analysts covering Ophthotech Corporation (NASDAQ:OPHT), 2 have Buy rating, 2 Sell and 9 Hold. Therefore 15% are positive. Ophthotech Corporation had 29 analyst reports since August 4, 2015 according to SRatingsIntel. Stifel Nicolaus maintained Ophthotech Corporation (NASDAQ:OPHT) on Tuesday, September 19 with “Hold” rating. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, August 6. JP Morgan downgraded Ophthotech Corporation (NASDAQ:OPHT) on Monday, March 19 to “Underweight” rating. On Friday, October 27 the stock rating was maintained by Stifel Nicolaus with “Hold”. The stock of Ophthotech Corporation (NASDAQ:OPHT) earned “Buy” rating by Citigroup on Thursday, August 4. The firm has “Neutral” rating by JP Morgan given on Monday, December 12. The stock of Ophthotech Corporation (NASDAQ:OPHT) earned “Mkt Perform” rating by Leerink Swann on Monday, December 12. The stock has “Neutral” rating by Chardan Capital Markets on Monday, December 12. As per Friday, August 7, the company rating was downgraded by Goldman Sachs. SunTrust downgraded Ophthotech Corporation (NASDAQ:OPHT) on Monday, December 12 to “Hold” rating.

Investors sentiment increased to 1 in 2018 Q1. Its up 0.04, from 0.96 in 2017Q4. It improved, as 6 investors sold OPHT shares while 17 reduced holdings. 9 funds opened positions while 14 raised stakes. 18.18 million shares or 0.32% less from 18.24 million shares in 2017Q4 were reported. Endurance Wealth Inc owns 1,500 shares for 0% of their portfolio. Architects Inc holds 0% or 200 shares. Moreover, National Bank Of America De has 0% invested in Ophthotech Corporation (NASDAQ:OPHT). Gsa Capital Ptnrs Llp holds 0.03% or 223,249 shares. Creative Planning reported 0% in Ophthotech Corporation (NASDAQ:OPHT). Highlander Cap Ltd Company invested in 6,000 shares or 0.01% of the stock. Bnp Paribas Arbitrage invested in 0% or 60 shares. California Public Employees Retirement System reported 0% stake. Royal Bank & Trust Of Canada holds 0% in Ophthotech Corporation (NASDAQ:OPHT) or 1,815 shares. Cetera Advisor holds 11,284 shares. Vanguard Group Incorporated Inc holds 1.65 million shares or 0% of its portfolio. Deutsche Fincl Bank Ag owns 0% invested in Ophthotech Corporation (NASDAQ:OPHT) for 786,476 shares. Morgan Stanley has 0% invested in Ophthotech Corporation (NASDAQ:OPHT). Walleye Trading Ltd Co invested in 10,000 shares. 750 were accumulated by Atwood & Palmer.

Since April 1, 2018, it had 0 insider purchases, and 2 selling transactions for $25,726 activity. $7,332 worth of Ophthotech Corporation (NASDAQ:OPHT) was sold by Carroll David Francis.

Another recent and important Ophthotech Corporation (NASDAQ:OPHT) news was published by Seekingalpha.com which published an article titled: “Ophthotech Corp (OPHT) CEO Glenn Sblendorio on Q2 2018 Results – Earnings Call Transcript” on August 01, 2018.

Acadian Asset Management Llc, which manages about $65.15 billion and $23.12B US Long portfolio, decreased its stake in Angiodynamics Inc (NASDAQ:ANGO) by 28,574 shares to 79,965 shares, valued at $1.38M in 2018Q1, according to the filing. It also reduced its holding in National Western Life Group by 1,479 shares in the quarter, leaving it with 8,123 shares, and cut its stake in Just Energy Group Inc (NYSE:JE).

More news for Henry Schein, Inc. (NASDAQ:HSIC) were recently published by: Nasdaq.com, which released: “Investor Expectations to Drive Momentum within Lennar, Symantec, El Pollo Loco, Apollo Commercial Real Estate …” on July 27, 2018. Seekingalpha.com‘s article titled: “Market Has Forgiven Stocks – Cramer’s Mad Money (8/6/18)” and published on August 07, 2018 is yet another important article.

Among 23 analysts covering Henry Schein Inc. (NASDAQ:HSIC), 12 have Buy rating, 1 Sell and 10 Hold. Therefore 52% are positive. Henry Schein Inc. had 58 analyst reports since July 31, 2015 according to SRatingsIntel. Robert W. Baird maintained Henry Schein, Inc. (NASDAQ:HSIC) on Friday, March 9 with “Buy” rating. The rating was maintained by Credit Suisse on Tuesday, November 28 with “Hold”. The stock of Henry Schein, Inc. (NASDAQ:HSIC) has “Buy” rating given on Thursday, October 26 by Piper Jaffray. The company was maintained on Tuesday, November 7 by Leerink Swann. Deutsche Bank initiated the stock with “Buy” rating in Friday, December 8 report. The firm has “Market Perform” rating by Leerink Swann given on Wednesday, February 21. The company was downgraded on Friday, October 14 by Robert W. Baird. Leerink Swann upgraded the shares of HSIC in report on Wednesday, April 4 to “Outperform” rating. Goldman Sachs upgraded the stock to “Buy” rating in Tuesday, October 11 report. The rating was downgraded by Goldman Sachs to “Hold” on Tuesday, April 24.

Jlb & Associates Inc, which manages about $350.10 million and $464.63 million US Long portfolio, decreased its stake in Mastercard (NYSE:MA) by 4,908 shares to 125,450 shares, valued at $21.97M in 2018Q1, according to the filing. It also reduced its holding in Ametek (NYSE:AME) by 5,507 shares in the quarter, leaving it with 124,391 shares, and cut its stake in Ross Stores (NASDAQ:ROST).

Since June 11, 2018, it had 0 insider purchases, and 2 insider sales for $1.11 million activity. Brons Paul also sold $351,678 worth of Henry Schein, Inc. (NASDAQ:HSIC) on Monday, June 11.

Investors sentiment increased to 0.86 in Q1 2018. Its up 0.03, from 0.83 in 2017Q4. It improved, as 55 investors sold HSIC shares while 169 reduced holdings. 61 funds opened positions while 132 raised stakes. 158.34 million shares or 8.33% more from 146.17 million shares in 2017Q4 were reported. 2.00M are owned by Geode Cap Mngmt Limited Liability Corporation. Shelton Capital Mngmt holds 0.05% in Henry Schein, Inc. (NASDAQ:HSIC) or 12,450 shares. Hudock Ltd owns 0% invested in Henry Schein, Inc. (NASDAQ:HSIC) for 100 shares. Los Angeles Capital Mgmt And Equity reported 62,680 shares or 0.02% of all its holdings. Legal General Public Ltd Co invested 0.05% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC). 20,740 are held by Advsr Asset Mngmt Incorporated. Fdx Advsr Incorporated has 10,271 shares for 0.02% of their portfolio. Rafferty Asset Management Ltd Liability Corp invested in 0.02% or 23,837 shares. Goldman Sachs Group holds 0.03% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC) for 1.69M shares. 6,175 are owned by Cibc Bank & Trust Usa. Alliancebernstein Limited Partnership, New York-based fund reported 323,825 shares. Lincoln Cap Lc, Nebraska-based fund reported 6,500 shares. 94,545 were reported by Voya Management Ltd Liability Corporation. Prudential Financial holds 0.02% of its portfolio in Henry Schein, Inc. (NASDAQ:HSIC) for 173,000 shares. Sheets Smith Wealth Management holds 1.27% or 78,460 shares.

Henry Schein, Inc. (NASDAQ:HSIC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts